Although laboratory rats and mice are the most common animal models used in biomedical research, research involving chickens ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

Vitiligo, a skin condition affecting millions worldwide, manifests as patches of skin losing their ... Without this natural defense, the depigmented areas are at risk of sunburn and long-term ...

These patches have defined edges, making them easier to spot. Vitiligo in infancy is not common. Only 25% of people with vitiligo develop the condition before the age of 8 years. There is no cure ...

Aesthetic procedures like permanent makeup are usually deemed as “kaartehan” (vanity), but according to Kristine Lucas, a ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Vitiligo is a long-term skin condition characterized by the loss of pigmentation in certain areas of the skin. This results in white patches appearing ... full of supposed cures for vitiligo ...

But she has now come to accept her skin condition, called vitiligo ... tame the pale patches, but more patches appeared. Frustrated, she decided at age 16 to forgo any sort of treatment altogether.